Purchase Order 75F40123P00136
Award Date 8/14/23
Potential Completion Date 9/2/24
Potential Value $120K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Marlborough, MA 01752, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $368,778.39 delivery order contract to Global Life Sciences Solutions USA LLC under its Multiple Award Schedule contract vehicle. The contract calls for Global Life Sciences Solutions USA LLC to provide one Biacore T200 Surface Plasmon Resonance system to be delivered to the place of performance in Marlborough, Massachusetts by November 28, 2023. The pricing for this firm fixed price contract is fixed...
- The Department of Health and Human Services Food and Drug Administration awarded a $245,000 firm fixed price purchase order to Government Scientific Source Inc., doing business as G S S, for a BIACORE 1K SYSTEM. The contract has a period of performance from September 30, 2023 through March 31, 2024 and will be performed in Herndon, Virginia. The original solicitation, numbered 75F40123Q0047, sought a BIACORE 1K SYSTEM as described in the request for quotes, with responses due by September 15,...
- Global Life Sciences Solutions USA LLC, a subsidiary of Danaher Corporation, was awarded a firm fixed price purchase order by the Department of Health and Human Services Food and Drug Administration for $17,733. The contract has no set-aside designation and is to be completed by September 8, 2021. Under this contract, Global Life Sciences Solutions will provide scientific equipment, supplies, and services to support the FDA's biomedical research and laboratory operations in Silver Spring,...
- The Department of Health and Human Services Food and Drug Administration awarded a $35,593.65 firm fixed price delivery order to Global Life Sciences Solutions USA LLC under the Scientific Equipment and Services Federal Supply Schedule contract. This order is for the delivery of a fast protein liquid chromatography system to the agency's facility in Silver Spring, Maryland by August 27, 2020. Global Life Sciences Solutions USA LLC is a subsidiary of Danaher Corporation and will provide the...
- The Food and Drug Administration awarded a firm fixed price purchase order contract valued at $87,360 to Global Life Sciences Solutions USA LLC for preventive maintenance of a Surface Plasmon Resonance Biacore T200 instrument located in Silver Spring, Maryland. The award includes an initial one-year maintenance period with three optional one-year extensions through February 2026. Global Life Sciences Solutions will provide preventive maintenance services to ensure continuity of operations for...
- The Food and Drug Administration awarded Global Life Sciences Solutions USA LLC a $337,420.74 firm fixed price delivery order against the Scientific Equipment and Services GSA Schedule for a surface plasmon resonance instrument. As a wholly owned subsidiary of Danaher Corporation, Global Life Sciences Solutions will provide the requested scientific equipment to support research activities at the place of performance in Marlborough, Massachusetts. No set-aside designation was used for this...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $287,976.64 firm fixed price purchase order to Molecular Devices, LLC for a BLI Detection System. As a prime contractor, Molecular Devices will deliver the requested detection system to support HHS FDA programs. Performance will occur at Molecular Devices' San Jose, California location from March 2020 through August 2020. No set aside designation or subcontractors were indicated. The award provides the...
- The Food and Drug Administration (FDA) awarded a $465,096.00 firm fixed-price purchase order to Global Life Sciences Solutions USA LLC for the delivery of an XDR-50 single use bioreactor system or equivalent with accessories, training, and installation. The bioreactor system will support the FDA's Center for Drug Evaluation and Research Division of Product Quality Research. The contract has a two-year manufacturer's warranty and a performance period through May 18, 2025. This award was not set...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Global Life Sciences Solutions USA LLC for preventive maintenance and repair services for a Cytiva Biacore T200 surface plasmon resonance (SPR) instrument. The contract has a ceiling value of $83,520.00 and a period of performance through August 18, 2025. No set-aside designation was used. Global Life Sciences Solutions USA LLC is a provider of technologies and services that advance and accelerate...
- This is a $133,169.20 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Global Life Sciences Solutions USA LLC, a for-profit limited liability company that provides scientific equipment, maintenance services, biological materials, and medical supplies to federal agencies. The contract is for a BIOMOLECULAR SCANNING IMAGER SYSTEM, which supports the FDA's BIO-MOLECULAR IMAGING SYSTEM program. There is no set-aside designation for this award. Global Life Sciences...
The Department of Health and Human Services' Food and Drug Administration awarded a $120,000 firm fixed price purchase order to Global Life Sciences Solutions USA LLC for a BIACORE 1K+ Upgrade Kit. The prime contractor, a subsidiary of Danaher Corporation, will provide the upgrade kit to support the FDA's work. Performance will take place in Marlborough, Massachusetts over approximately one year. No set aside designation or subcontractors were indicated. The award falls under HHS/FDA programs for medical device evaluation and is consistent with the agency's mission to protect public health through ensuring the safety and effectiveness of medical technologies.
Generated 12/20/23, 1:53 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $120.0k | 8/14/23 |